Primary infarct artery stenting has the potential to advance treatment of a
cute myocardial infarction, The postulated mechanisms of the benefit of ste
nting in acute myocardial infarction are the achievement of on acute optima
l angiographic result and correction of any residual dissection to decrease
the incidence of early and late restenosis and reocclusion and of the corr
elated events such as fatal and nonfatal reinfarction and repeat target ves
sel revascularization for recurrent ischemia. The results of 5 completed ra
ndomized trials corn paring primary stenting with primary percutaneous tran
sluminal coronary angioplasty show a lower incidence of the composite end p
oint of death, myocardial infarction, and repeat target vessel revasculariz
ation in the stent groups as compared with the angioplasty groups and suppo
rt the more extensive use of stents in patients with acute myocardial infar
ction. The efforts of the next years will be focused on further refinement
of stent design and composition and the evaluation of pharmacological agent
s effective in restoring myocardial reperfusion to the fullest extent.